drugset
drugset / Trial / NCT04713488

An Open Study on the Safety, Tolerability, and Immunogenicity of "Sputnik Light" Vaccine

NCT04713488 ↗

Phase 1/2 Unknown 110 enrolled Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation Russian Direct Investment Fund · collab
NaSingle-groupOpen-labelPrevention

Summary

Phase I-II open prospective, two-stage, non-randomized study in healthy volunteers.

Timeline

Start
2021-01-15
Primary completion
2021-07-20
Completion
2021-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Sputnik Light Vaccine 0.5 ml Intramuscular

Indications

No indication recorded.